MicroCHIPS Inc. may have been the result of divine inspiration (as the story goes, MIT professor Robert Langer thought of the idea while watching PBS), but it took people like Maggie Pax to turn his vision into a suite of implantable devices that could one day revolutionize medicine.
Pax, the VP of business development for MicroCHIPS, has been at the Bedford, Mass.-based implantable drug delivery company since 2006. She’s charged with figuring out a way to get the best return on investment from the company’s technology platform. Through targeted partnerships with larger firms and carefully vetting which markets to enter, Pax says MicroCHIPS has leveraged its intellectual property, technology platform and talent pool to play in several arenas at once. She says that’s the best way to mitigate risk in an inherently risky business.
MassDevice sat down with Pax in 2009 to discuss what’s happening at MicroCHIPS.